Par Drugs and Chemicals, a company in the Pharmaceuticals industry, reported revenue of ₹27 crore and net profit of ₹2.63 crore for the September 2026 quarter.
Par Drugs and Chemicals (NSE: PAR-BE) closed at ₹112.06 on 20 Nov 2026. Its market capitalisation is ₹138 crore and it trades at 10.6 times earnings.
Incorporated in 1982, Par Drugs & Chemicals Ltd manufactures APIs and Fine Chemicals
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.